Miniatura

Fitxers

ding2017_2491.pdf (949.39 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2017-04-03

Llicència de publicació

cc0 (c) Ding et al., 2017
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/110394

Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1371/journal.pntd.0005516

Resum

The global prevalence of malaria has decreased over the past fifteen years, but similar gains have not been realized against Plasmodium vivax because this species is less responsive to conventional malaria control interventions aimed principally at P. falciparum. Approximately half of all malaria cases outside of Africa are caused by P. vivax. This species places dormant forms in human liver that cause repeated clinical attacks without involving another mosquito bite. The diagnosis of acute patent P. vivax malaria relies primarily on light microscopy. Specific rapid diagnostic tests exist but typically perform relatively poorly compared to those for P. falciparum. Better diagnostic tests are needed for P. vivax. To guide their development, FIND, in collaboration with P. vivax experts, identified the specific diagnostic needs associated with this species and defined a series of three distinct target product profiles, each aimed at a particular diagnostic application: (i) point-of-care of acutely ill patients for clinical care purposes; (ii) point-of-care asymptomatic and otherwise sub-patent residents for public health purposes, e.g., mass screen and treat campaigns; and (iii) ultra-sensitive not point-of-care diagnosis for epidemiological research/surveillance purposes. This report presents and discusses the rationale for these P. vivax-specific diagnostic target product profiles. These contribute to the rational development of fit-for-purpose diagnostic tests suitable for the clinical management, control and elimination of P. vivax malaria.

Matèries

Plasmodium vivax, Malalties parasitàries

Matèries (anglès)

Plasmodium vivax, Parasitic diseases

Citació

Col·leccions

Articles publicats en revistes (ISGlobal)

Citació

DING, Xavier c., ADE, Maria paz, BAIRD, J. kevin, CHENG, Qin, CUNNINGHAM, Jane, DHORDA, Mehul, DRAKELEY, Chris, FELGER, Ingrid, GAMBOA, Dionicia, HARBERS, Matthias, HERRERA, Sócrates, LUCCHI, Naomi, MAYOR APARICIO, Alfredo gabriel, MUELLER, Ivo, SATTABONGKOT, Jetsumon, RATSIMBASON, Arsène, RICHARDS, Jack, TANNER, Marcel, GONZALEZ, Iveth j.. Defining the next generation of Plasmodium vivax diagnostic
                tests for control and elimination: Target product profiles. _PLoS Neglected Tropical Diseases_. 2017. Vol. 11, núm. 4, pàgs. e0005516. [consulta: 25 de gener de 2026]. ISSN: 1935-2727. [Disponible a: https://hdl.handle.net/2445/110394]

Exportar metadades

JSON - METS

Compartir registre